Global Regenerative Medicine Market Will Grow To Over $66 Billion By 2022, At a Significant CAGR Of 23.3%

Researchmoz added Most up-to-date research on "Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries" to its huge collection of research reports.

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine market was worth $18.9 billion in 2016 and will grow to over $66 billion by 2022, with a CAGR of 23.3% between this time frame. Within this market, the stem cell industry will grow significantly at a CAGR of over x% and reach $x billion by 2022. Tissue engineering is forecast to grow at a CAGR of x% to 2022 and potentially reach $x billion. This report describes the evolution of such a huge market in 15 chapters supported by over 350 tables and figures in 680 pages.

Request Sample Copy of Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=1846400

- An overview of regenerative medicine that includes: stem cells, allogenic and autogenic cells, umbilical cord blood banking, tissue engineering and CAR T therapies.
- Global regenerative medicine market, global breakdown, application breakdown and leading market players
- Detailed account of the stem cell industry market by geography, indication and company profiles
- Profiles, marketed/pipeline products, financial analysis and business strategy of the major companies in this space
- Focus on current trends, business environment, pipeline products, clinical trials, and future market forecast for regenerative medicine
- Insight into the challenges faced by stakeholders, particularly about the success vs. failure ratios in developing regenerative medicine drugs and therapies.
- Insight into the biobanking industry globally and its impact on the overall market
- Description and data for the prevalence of disease types that are addressed by regenerative medicine, stem cells, tissue engineering and CAR-T therapies
- Financial market forecast through 2022 with CAGR values of all market segments outlined in the objective
- SWOT analysis of the global market
- Geographical analysis and challenges within key topographies including the USA, Japan, South Korea, China and Europe

Table of Contents

1.0 Report Synopsis
1.1 Objectives of Report
1.2 Executive Summary
1.2 Key Questions Answered in this Report
1.3 Data Sources and Methodology

2.0 Introduction
2.1 Gurdon and Yamanaka Share the Nobel Prize
2.2 Stem Cell Clinical Trials: Initiated in 2010
2.3 Types of Stem Cells
2.4 Adult (Tissue) Stem Cells
2.5 Pluripotent Stem Cells
2.6 Somatic Cell Nuclear Transfer (SCNT)
2.7 Induced pluripotent Stem Cells (iPSC)
2.8 Mesenchymal Cells
2.8.1 MSCs in the Bone Marrow Stroma
2.8.2 Isolation, Marker Specificity and Functional Properties of MSCs
2.8.3 Oxygen Concentration and MSC Culture
2.8.4 Assays to Define MSCs
2.8.5 Differentiation Potential of MSCs
2.8.6 Therapeutic Potential of MSCs
2.8.7 Mesenchymal Stem Cells & Chronic Disease
2.8.8 MSCs and Amylotrophic Lateral Sclerosis
2.8.9 MSCs and Parkinson’s Disease
2.8.10 MSCs and Alzheimer Disease
2.8.11 MSCs and Rheumatoid Arthritis
2.8.12 MSCs and Type 1 Diabetes
2.8.13 MSCs and Cardiovascular Disease
2.9 Hematopoietic Stem and Progenitor Cells
2.9.1 In Vivo Assays for Hematopoietic Stem Cells
2.9.2 In Vitro Assays for Hematopoietic Stem and Progenitor Cells
2.9.3 Isolation of Hematopoietic Stem and Progenitor Cells
2.9.4 Culture of Hematopoietic Cells
2.9.5 Therapeutic uses of Hematopoietic Cells
2.10 Umbilical Cord Stem Cells
2.11 Heart Stem Cells
2.11.1 Cutting Edge Research in Heart Stem Cells
2.12 Mammary Stem Cells
2.12.1 Defining the Mammary Stem Cell
2.12.2 Influence of Model System on Stem Cell Identification
2.12.3 Breast Cancer Stem Cells
2.13 Neural Stem Cells
2.13.1 Identification of Neural Stem Cells
2.13.2 Function of Neural Stem Cells in Vivo
2.13.3 Neural Stem Cell Culture Systems
2.13.4 Isolation Strategies for Neural Stem Cells
2.13.5 Brain Tumour Stem Cells
2.13.6 Cutting Edge Research in Neural Stem Cells
2.14 Stem Cell Applications in Retinal Repair
2.14.1 Embryonic Stem Cells as Retina Therapeutics
2.14.2 Induced Pluripotent Stem Cells as Retina Therapeutics
2.14.3 Adipose Derived Mesenchymal Stem Cells as Retina Therapeutics
2.15 Liver Stem Cells
2.16 Gut Stem Cells
2.16 Pancreatic Stem Cells
2.17 Epidermal Stem Cells

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-regenerative-medicine-market-analysis-forecast-to-2022-stem-cells-tissue-engineering-biobanking-cart-industries-report.html/toc

3.0 Stem Cells and Clinical Trials
3.1 Introduction
3.2 Pluripotent Stem Cells
3.3 Limbal Stem Cells
3.4 Neural Stem Cells
3.5 Endothelial Stem or Progenitor Cells
3.6 Placental Stem Cells
3.7 Why Do Stem Cell Clinical Trials Fail?
3.8 What is the Future of Stem Cell Trials?
3.9 Cutting Edge Stem Cell Clinical Trials
3.10 Ocata Therapeutics Current Stem Cell Trials
3.11 CHA Biotech Current Stem Cell Trials
3.12 Pfizer Current Stem Cell Trials
3.13 GSK Current Stem Cell Trials
3.14 Bayer Current Stem Cell Trials
3.15 Mesoblast International Current Stem Cell Trials
3.16 Millennium Pharmaceutical Current Stem Cell Trial
3.17 AstraZeneca Current Stem Cell Trials
3.18 Merck Current Stem Cell Trials
3.19 Chimerix Current Stem Cell Trials
3.20 Eisai Current Stem Cell Trials
3.21 SanBio Current Stem Cell Trials
3.22 Celgene Current Stem Cell Trials
3.23 StemCells Current Stem Cell Trials
3.24 Genzyme (Sanofi) Current Stem Cell Trials
3.25 Teva Current Stem Cell Trials
3.26 MedImmune Current Stem Cell Trials
3.27 Janssen Current Stem Cell Trials
3.28 Seattle Genetics Current Stem Cell Trials
3.29 Baxter Healthcare Current Stem Cell Trials
3.30 InCyte Corp Current Stem Cell Trials

4.0 Stem Cells, Disruptive Technology, Drug Discovery & Toxicity Testing
4.1 Introduction
4.2 Case Study: Genentech and Stem Cell Technology
4.3 3D Sphere Culture Systems
4.4 Stem Cells and High Throughput Screening
4.4.1 Embryonic Stem Cells
4.4.2 Adult Stem Cells
4.4.3 Opportunities & Challenges
4.5 Genetic Instability of Stem Cells
4.6 Comprehensive in Vitro Proarrhythmia Assay (CiPA) & Cardiomyocytes
4.8 Coupling Precise Genome Editing (PGE) and iPSCs
4.9 Stem Cells & Toxicity Testing
4.9.1 Hepatotoxicity and iPSCs
4.9.2 Cardiotoxicity and iPSCs
4.9.3 Neurotoxicity and iPSCs
4.10 Stem Cell Disease Models
4.11 Defining Human Disease Specific Phenotypes
4.11.1 Molecular Phenotypes for Disease Modelling
4.11.2 Cellular Phenotypes for Disease Modelling
4.11.3 Physiological Phenotypes for Disease Modelling
4.11.4 Parkinson’s Disease
4.11.5 Alzheimer’s Disease
4.11.6 Amyotrophic Lateral Sclerosis
4.11.7 Huntington’s Disease
4.11.8 Spinal Muscular Atrophy
4.11.9 Down Syndrome
4.11.10 Cystic Fibrosis
4.11.11 Colorectal Cancer
4.12 Advantages of Stem Cell Derived Cells & Tissues for Drug Screening

5.0 Stem Cell Biomarkers
5.1 Pluripotent Stem Cell Biomarkers
5.2 Mesenchymal Stem Cell Biomarkers
5.3 Neural Stem Cell Biomarkers
5.4 Hematopoietic Stem Cell Biomarkers

Get PDF for More Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1846400

6.0 Manufacturing Stem Cell Products
6.1 Manufacturing Strategies For Stem Cell Products
6.2 BioProcess Economics for Stem Cell Products
6.3 Capital Investment
6.4 Cost of Goods
6.5 Bioprocess Economic Drivers & Strategies
6.6 hPSC Expansion & Differentiation using Planar Technology
6.7 hPSC Expansion using 3D Culture
6.8 Microcarrier Systems
6.9 Aggregate Suspension
6.10 Bioreactor Based Differentiation Strategy
6.11 Integrated hPSC Bioprocess Strategy
6.12 GMP Regulations and Stem Cell Products

Continue...

Regenerative Medicine Market In The US To Grow At A CAGR Of 23.53% During The Period 2017-2021 Key Vendors - Acelity, Medtronic, MiMedx, Organogenesis, Zimmer Biomet

Researchmoz added Most up-to-date research on "Regenerative Medicine Market in the US 2017-2021" to its huge collection of research reports.

Regenerative medicine is a bioproduct, which is developed by using translational research techniques such as molecular biology, tissue engineering, and gene engineering. Stem cells and tissue scaffolds have the effective therapeutic potential, which has increased the adoption of regenerative medicine in the US market. Stem cell therapy responds well to various treatments such as dermatological, macular, musculoskeletal, and cardiovascular applications. The regenerative medicine industry includes four key sectors, which help the vendors to develop regenerative medicine.

Technavios analysts forecast the Regenerative Medicine Market in the US to grow at a CAGR of 23.53% during the period 2017-2021.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1267270

Covered in this report
The report covers the present scenario and the growth prospects of the Regenerative Medicine Market in the US for 2017-2021. To calculate the market size, the report considers the sales, volume, and value of regenerative medicine market in the US.

Regenerative Medicine Market in the US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Acelity
Medtronic
MiMedx
Organogenesis
Zimmer Biomet

Browse Detail Report With Full TOC @ http://www.researchmoz.us/regenerative-medicine-market-in-the-us-2017-2021-report.html

Other prominent vendors
ACE Surgical Supply
Acera Surgical
Acologix
Advanced Biologics
AlloCure
AlloSource
Alphatec Spine
ANTEROGEN
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bacterin International
Baxter
Bellicum Pharmaceuticals
BioCardia
Biogen
BioRestorative Therapies
Biostage
Bio-Tissue
BioTissue
bluebird bio
BONESUPPORT
BrainStorm Cell Therapeutics
Caladrius
Calimmune
Capricor Therapeutics
CELGENE
Cell Medica
Cell Therapy
CellBioMed
CellSeed
Celyad
CESCA THERAPEUTICS
CTM CRC
CryoLife
Cynata
Cytori Therapeutics
Dendreon Pharmaceuticals
DiscGenics
Fate Therapeutics
Fibrocell Science
Forticell Bioscience
Fortress Biotech
FUJIFILM Holdings
Gamida Cell
Geron
GlaxoSmithKline
Healthpoint (acquired by Smith & Nephew)
Histogen
Histogenics
Holostem Terapie Avanzate
Humacyte
Immunocellular Therapeutics
Integra LifeSciences
Intercytex
InVivo Therapeutics
iSTO Biologics
Janssen Pharmaceuticals
Juno Therapeutics
Juventas Therapeutics
Kiadis Pharma
LifeCell
LifeNet Health
Living Cell Technologies
Lonza
MaxCyte
MEDIPOST
Mesoblast
Nanofiber Solutions
Nanotope
Neuralstem
NewLink Genetics
Northwest Biotherapeutics
NovaRx
Opexa Therapeutics
ORGANOVO HOLDINGS
Orteq
Orthofix Holdings
Osiris Therapeutics
Pfizer
PHARMICELL
Pluristem
Prima BioMed
Q Therapeutics
Regenerex
Regenerys
Regience
Regrow
RENOVA THERAPEUTICS
RepliCel
ReproCELL
RhinoCyte
Rohto Pharma
RTI Surgical
SanBio
Sangamo Therapeutics
Shanghai Sunway Biotech
Shire
Stratatech
SURGILOGIX
Synergistic Technologies
TAKARA BIO
tella
Tissue Genesis
TissueGene
Txcell
VentriNova
Vericel
ViaCyte
VistaGen Therapeutics

Market driver
CVD and diabetes in young adult and aging population
For a full, detailed list, view our report

Market challenge
High cost of clinical trial
For a full, detailed list, view our report

Market trend
Increasing strategic alliances
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1267270

Global Regenerative Medicine Industry Will Grow At Steadily A CAGR Of 20.7% During The Period 2016-2020

Researchmoz added Most up-to-date research on "Global Regenerative Medicine Market 2016-2020" to its huge collection of research reports.

Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products.

Technavios analysts forecast the global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2016-2020. To calculate the market size, we used the revenue generated from the sales of various types of regenerative medicine products.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=724221

Technavio's report, Global Regenerative Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Acelity
Medtronic
MiMedx Group
Organogenesis
UniQure
Zimmer Biomet

Other prominent vendors
ACE Surgical Supply
Acologix
Advanced Biologics
AlloCure
Allosource
Alphatec Spine
Altrika
Amorcyte
Anterogen
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bacterin International
Baxter
Bellicum Pharmaceuticals
BioCardia
Biogen Idec
BioRestorative Therapies
Biostage Technologies
Bluebird Bio
BONESUPPORT
BrainStorm Cell Therapeutics
Caladrius Biosciences
Calimmune
Capricor Therapeutics
Celgene
Cell Medica
CellSeed
Cell Therapy
Celyad
CESCA THERAPEUTICS
CRC for Cell Therapy Manufacturing
Cryolife
Cynata Therapeutics
Cytori Therapeutics
Dendreon
DiscGenics
Fate Therapeutics
Fibrocell Science
Forticell Bioscience
Fortress Biotech
FUJIFILM
Gamida Cell
Geron
GlaxoSmithKline
Healthpoint
Histogen
Histogenics
Holostem Terapie Avanzate
Humacyte
ImmunoCellular Therapeutics
Integra LifeSciences
Intercytex
InVivo Therapeutics
iSTO Technologies
Janssen Pharma
Juno Therapeutics
Juventas Therapeutics
Kensey Nash
Kiadis Pharma
Kinetic Concept
LifeCell
LifeNet Health
Living Cell Technologies
Lonza
MaxCyte
MEDIPOST
Mesoblast
Nanofiber Solutions CTO
Nanotope
NeoStem
Neuralstem
Newlink Genetics
Northwest Biotherapeutics
NovaRx
Ocata Therapeutics
Opexa Therapeutics
Organovo Holdings
Orteg
Orthofix
Osiris Therapeutics
Osteotech
Pfizer
Pharmicell
Pluristem Therapeutics
Prima BioMed
Q Therapeutics
Regenerex
Regenerys
Regience
Regrow
Replicel
ReproCELL
Renova Therapeutics
RhinoCyte
Rohto Pharmaceutical
RTI Surgical
SanBio
Sangamo BioSciences
Shanghai Sunway Biotech
Shire Regenerative Medicine
StemCells
Stratech
Takara Bio
TEI Biosciences
tella
Tengion
Tissue Genesis
TissueGene
Txcell
VentriNova
Vericel
ViaCyte
Vistagen

Market driver
Increased focus on cell therapy products
For a full, detailed list, view our report

Market challenge
High cost and failure rate in clinical trials
For a full, detailed list, view our report

Market trend
Increased number of regenerative medicine in product line
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=724221